Container for pharmaceutical substances

• US 5,894,949 A
• Filed: 09/12/1996
• Issued: 04/20/1999
• Est. Priority Date: 03/17/1994
• Status: Expired due to Fees

• Current Assignee: Smithkline Beecham PLC
• Original Assignee: Smithkline Beecham PLC
• Inventors: Taskis, Charles Bernard, Whatmore, Paul John
• Primary Examiner(s): Pascua, Jes F.
• Application Number:
  US08/718,300
• Time in Patent Office: 950 Days
• Field of Search: 215/247, 215/248, 215/261, 215/308, 215/364, 220/371, 220/522
• US Class Current: 215/247
• CPC Class Codes: B65D 51/002 Closures to be pierced by an extracting-device for the contents and fixed on the container by separate retaining means
• CPC Class Codes: B65D 51/30 for desiccators

Abstract

A container having a closure comprising a closure wall having a puncturable region in communication with the interior of the vessel, and having on an inwardly facing region of the closure wall a desiccant material separated from the interior of the vessel by a semi-permeable membrane which permits transmission of water vapor therethrough but is substantially impermeable to liquid water.

Claims

1. A container comprising a vessel having a mouth opening and a closure capable of sealing engagement with the mouth opening, the mouth opening being defined by the rim of the neck of the vessel, the closure comprising a closure wall having a puncturable region therein in communication with the interior of the vessel and comprising materials from the group consisting of plastic materials, elastomeric materials or composite metal and plastic or elastomeric materials, the puncturable region of the closure wall comprising a thinned elastomeric region which is capable of resiliently sealing around a hypodermic needle when said needle is inserted therethrough, and having on an inwardly facing region of the closure wall a desiccant material separated from the interior of the vessel by a semi-permeable membrane which permits transmission of water vapor therethrough but is substantially impermeable to liquid water.

2. A container according to claim 1 wherein the dessicant is located on only part of the closure wall and the puncturable region is situated between areas of the closure wall on which the desiccant is present.

3. A container according to claim 2 wherein the desiccant material is distributed in the form of a ring shape on the closure wall, with the puncturable region within the ring.

4. A container according to claim 3 characterised in that a ring-shaped distribution of desiccant is located in a holder defining a ring-shaped cavity which extends inwardly from the closure wall, the cavity opening into the interior of the container when the closure is in place on the vessel.

5. A container according to claim 4 wherein the holder is in the form of two generally concentric walls comprising an inner wall and an outer wall extending inwardly from the closure wall, the space between the walls defining the ring-shaped cavity, and the central space within the inner wall defining a central passage in direct communication with the puncturable region.

6. A container according to claim 5 characterised in that the holder is formed integrally with the closure wall.

7. A container according to claim 6 wherein the outer wall has an outer surface which engages the rim of the mouth.

8. A container according to claim 7 wherein the central passage has a base wall which includes the puncturable region.

9. A container according to claim 8 characterised in that the desiccant material is compacted into a ring shape.

10. A container according to claim 9 wherein the semi-permeable membrane is a continuous film of material.

11. A container according to claim 10 characterised in that the semi-permeable membrane is a thin film of a plastics material.

12. A container according to claim 11 wherein the plastics material is selected from the group consisting of polyolefins, polystyrene, polyamides, polyesters and halogenated polyvinyls.

13. A container according to claim 12 characterised in that the cavity is a ring-shaped cavity between generally concentric cavity-defining walls, and the membrane covers the opening of the cavity into the interior of the vessel.

14. A container according to claim 13 characterised in that in addition to covering the opening of the cavity into the interior of the vessel, the membrane also covers the central space within the ring.

15. A container according to claim 14 characterised in that the membrane is integral with the closure.

16. A container according to claim 15 characterised in that the container contains a formulation of potassium clavulanate and sodium amoxycillin.